drugset / Trial / NCT04453800

The Efficacy and Safety of Sofadil for Injection in the Treatment of Acute Ischemic Stroke

NCT04453800 ↗

Phase 2 Completed 236 enrolled Peking University Third Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the efficacy and safety of sofadil injection in the treatment of acute ischemic stroke

Timeline

Start
2016-10-01
Primary completion
2018-01-01
Completion
2018-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject sofadil Unknown 250 mg Intravenous
Subject sofadil Unknown 500 mg Intravenous

Indications